Related Experiment Videos
Clinical studies in benign (Becker type) X-linked muscular dystrophy
Clinical Genetics
|October 1, 1976
Summary
Becker type X-linked muscular dystrophy presents with proximal muscle weakness and calf pseudohypertrophy. Distinguishing it from Duchenne muscular dystrophy relies on the age patients become chair-bound.
Area of Science:
- Neurology
- Genetics
- Clinical Medicine
Background:
- Becker type X-linked muscular dystrophy is a genetic neuromuscular disorder.
- Characterized by progressive muscle weakness, predominantly affecting proximal muscles.
- Often presents with calf pseudohypertrophy, particularly in early stages.
Purpose of the Study:
- To detail clinical findings in Becker type muscular dystrophy.
- To compare Becker type with Duchenne muscular dystrophy.
- To identify key diagnostic distinctions between the two conditions.
Main Methods:
- Studied ten families with Becker type X-linked muscular dystrophy (67 affected males).
- Collected clinical data, including age of becoming chair-bound and cardiac involvement.
- Performed electrocardiographic studies and measured serum creatine kinase levels.
Main Results:
- Becker type muscular dystrophy shows predominantly proximal myopathy and calf pseudohypertrophy.
- Contractures are not an early feature; cardiac involvement is a late manifestation.
- Age of becoming chair-bound is the most reliable differentiator from Duchenne muscular dystrophy.
- Electrocardiographic findings were not consistently abnormal; serum creatine kinase levels were elevated, aiding preclinical case identification.
Conclusions:
- Becker type muscular dystrophy has distinct clinical features compared to Duchenne muscular dystrophy.
- Age of becoming chair-bound is a crucial diagnostic marker.
- Elevated serum creatine kinase levels can help identify preclinical cases of Becker type muscular dystrophy.